Ultra-processed foods increase the risk of a repeat heart attack or stroke For CVD patients, researchers explained, even a diet that appears to be healthy could be doing significant damage. Read more about Ultra-processed foods increase the risk of a repeat heart attack or stroke
Medicare spending on cardiology, interventional cardiology declined $906M in 2020 The American Medical Association highlighted Medicare spending for all specialties in a new report. Read more about Medicare spending on cardiology, interventional cardiology declined $906M in 2020
2 new studies confirm the ‘very low’ risk of myocarditis after COVID-19 vaccination “The results of these two studies are valuable for doctors, patients, and the public to reduce the fear of myocarditis as a reason for excluding young people from vaccination," one specialist said. Read more about 2 new studies confirm the ‘very low’ risk of myocarditis after COVID-19 vaccination
Predicting when T2D patients may experience a cardiovascular event The group's prediction model performed well, though some modifications are still needed before it is ready for prime time. Read more about Predicting when T2D patients may experience a cardiovascular event
DOACs outperform VKAs among cardiac amyloidosis patients with HF, AFib Outcomes from patients prescribed apixaban, rivaroxaban or dabigatran were compared with outcomes from patients given warfarin. Read more about DOACs outperform VKAs among cardiac amyloidosis patients with HF, AFib
How major life events can take a toll on the heart Staying active during significant life moments is vital, according to a new guidance from the American Heart Association.Read more about How major life events can take a toll on the heart
Cardiologist shares story after testing positive for Omicron COVID-19 variant—says he caught it during cardiology conference The cardiologist believes he was infected while in London. His symptoms remain mild. Read more about Cardiologist shares story after testing positive for Omicron COVID-19 variant—says he caught it during cardiology conference
SGLT2 inhibitors lower risk of HFpEF, new meta-analysis confirms Patients taking SGLT2 inhibitors were 22% less likely to die from heart-related causes. Read more about SGLT2 inhibitors lower risk of HFpEF, new meta-analysis confirms
FDA announces Class I recall of percutaneous thrombolytic device after multiple complaints The device is breaking during use, an issue that may require a catheter-based intervention or even surgery. Read more about FDA announces Class I recall of percutaneous thrombolytic device after multiple complaints
Trying to anticipate major AFib events among HCM patients Old age, a history of arrhythmia and obesity are just some of the factors clinicians should keep in mind when treating HCM patients. Read more about Trying to anticipate major AFib events among HCM patients
